METTL3‐mediated m6A mRNA contributes to the resistance of carbon‐ion radiotherapy in non‐small‐cell lung cancer

Lung cancer is one of the leading causes of death among cancer patients worldwide. Carbon‐ion radiotherapy is a radical nonsurgical treatment with high local control rates and no serious adverse events. N6‐methyladenosine (m6A) modification is one of the most common chemical modifications in eukaryo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaofeng, Zhang, Peiru, Huang, Yangle, Shi, Weizhong, Mao, Jingfang, Ma, Ningyi, Kong, Lin, Guo, Lin, Liu, Jinlong, Chen, Jian, Lu, Renquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807515/
https://www.ncbi.nlm.nih.gov/pubmed/36114749
http://dx.doi.org/10.1111/cas.15590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807515/
https://www.ncbi.nlm.nih.gov/pubmed/36114749
http://dx.doi.org/10.1111/cas.15590

Ejemplares similares